Trimetazidine – Cardiology MCQ
Trimetazidine is an antianginal agent which acts by inhibition of:
A. Beta oxidation of fatty acids
B. Anaerobic metabolism of glucose
C. Calcium channels
D. Beta adrenergic receptors
Please check the YouTube video above for discussion
Related Posts
-
Cardiology MCQ – Classic cardiogenic shock – Answer
No Comments | Dec 18, 2019 -
Kussmaul sign – Cardiology MCQ
No Comments | May 1, 2011 -
Graham Steell murmur – Cardiology MCQ
No Comments | Oct 30, 2013 -
Riociguat – Cardiology MCQ
No Comments | May 16, 2015
About The Author
Johnson Francis
Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal